Clinical trial
Optimal Approach for Analysis of Case-Control Genetic Association Studies
NCT00241709 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00241709 |
|---|---|
| Title | Optimal Approach for Analysis of Case-Control Genetic Association Studies |
| Official title | Case-Control Association Studies and Genetic Confounding |
| Acronym | GALA 1 |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Lung Diseases, Asthma |
| Enrollment | 800 |
| Start date | Aug 1, 2005 |
| Primary completion | Jun 1, 2010 |
| First posted | Oct 19, 2005 |
| Last update posted | Mar 11, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: